tiprankstipranks
Trending News
More News >
Lisata Therapeutics (LSTA)
NASDAQ:LSTA
US Market

Lisata Therapeutics (LSTA) Income Statement

Compare
1,037 Followers

Lisata Therapeutics Income Statement

Last quarter (Q1 2025), Lisata Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Lisata Therapeutics's net income was $-4.72M. See Lisata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.00M$ 0.00$ 121.37M$ 0.00$ 0.00
Gross Profit
$ 826.00K$ -189.00K$ 63.77M$ -55.00K$ -63.00K
Operating Expenses
$ 23.41M$ 25.71M$ 57.60M$ 29.05M$ 19.14M
Depreciation and Amortization
$ 174.00K$ 189.00K$ 69.00K$ 55.00K$ 63.00K
EBITDA
$ -22.23M$ -25.52M$ -115.20M$ -29.15M$ -19.08M
Operating Income
$ -22.41M$ -25.71M$ -27.21M$ -29.05M$ -19.14M
Other Income/Expenses
$ 1.63M$ 2.54M$ 897.00K$ 76.00K$ 132.00K
Pretax Income
$ -20.78M$ -23.17M$ -56.70M$ -28.97M$ -19.01M
Net Income
$ -19.98M$ -20.84M$ -54.23M$ -27.47M$ -8.15M
Per Share Metrics
Basic EPS
$ -2.40$ -2.58$ -10.47$ -7.45$ -7.91
Diluted EPS
$ -2.40$ -2.58$ -10.47$ -7.45$ -7.91
Weighted Average Shares Outstanding
8.33M 8.07M 5.18M 3.69M 1.03M
Weighted Average Shares Outstanding (Diluted)
8.33M 8.07M 5.18M 3.69M 1.03M
Currency in USD

Lisata Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis